Lyra therapeutics to present at upcoming investor conferences

Watertown, mass. , may 26, 2022 /prnewswire/ -- lyra therapeutics, inc. (nasdaq: lyra), a clinical-stage therapeutics company leveraging its proprietary xtreo™ platform to enable precise, sustained and local delivery of medications to the ear, nose and throat (ent) passages and other diseased tissues, today announced that maria palasis, ph.d.
LYRA Ratings Summary
LYRA Quant Ranking